AUTHOR=Pollak Nina M. , Rawle Daniel J. , Yan Kexin , Buckley Cameron , Le Thuy T. , Wang Claire Y. T. , Ertl Nicole G. , van Huyssteen Karla , Crkvencic Nicole , Hashmi Misha , Lyons Russell E. , Whiley David M. , Suhrbier Andreas , Macdonald Joanne TITLE=Rapid inactivation and sample preparation for SARS-CoV-2 PCR-based diagnostics using TNA-Cifer Reagent E JOURNAL=Frontiers in Microbiology VOLUME=14 YEAR=2023 URL=https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2023.1238542 DOI=10.3389/fmicb.2023.1238542 ISSN=1664-302X ABSTRACT=
RT-qPCR remains a key diagnostic methodology for COVID-19/SARS-CoV-2. Typically, nasal or saliva swabs from patients are placed in virus transport media (VTM), RNA is extracted at the pathology laboratory, and viral RNA is measured using RT-qPCR. In this study, we describe the use of TNA-Cifer Reagent E in a pre-clinical evaluation study to inactivate SARS-CoV-2 as well as prepare samples for RT-qPCR. Adding 1 part TNA-Cifer Reagent E to 5 parts medium containing SARS-CoV-2 for 10 min at room temperature inactivated the virus and permitted RT-qPCR detection. TNA-Cifer Reagent E was compared with established column-based RNA extraction and purification methodology using a panel of human clinical nasal swab samples (